Adimab, Inc. Receives Series C Funding Round

  • Feed Type
  • Date
    11/20/2008
  • Company Name
    Adimab, Inc.
  • Mailing Address
    16 Cavendish Court Lebanon, NH 03766
  • Company Description
    Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners.
  • Website
    http://www.adimab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to increase the capacity for conducting multiple parallel discovery programs as well as automating several aspects of our antibody discovery process.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    Borealis Ventures
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Polaris Venture Partners

Trending on Xconomy